Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Can Exosomes Unlock Nanomedicine’s Regenerative Medicine Potential?
NurExone CEO Lior Shaltiel discusses the company’s exosome-based approach to nerve regeneration, the manufacturing hurdles facing the field, and what it will take to bring nanotechnology therapeutics to patients